secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERU INC. (VERU)
CIK:        0000863894
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001437749-25-000208
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 1.02, 2.01, 2.04, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Veru Inc. sells FC2 female condom business for $18M, netting ~$12.5M after change-of-control payment
--------------------------------------------------------------------------------

- Sold FC2 female condom business to Clear Future, Inc., for $18M cash, subject to working capital adjustment.
- Net proceeds to Veru approximately $12.5M after $4.2M change-of-control payment to SWK Funding LLC.
- Royalty Agreement with SWK terminated upon payment; related $9.9M liability extinguished.
- Headcount reduced by ~90% (from 210 to 22) as Veru focuses on biopharmaceutical pipeline.
- Topline results from Phase 2b enobosarm weight loss trial expected in January 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/863894/000143774925000208/0001437749-25-000208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/863894/000143774925000208/veru20241220_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-000208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer